Download PDF
1 / Pages

Other users also viewed these articles

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;
10.1016/j.aohep.2024.101774
Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis? Luciana Agoglia; Ana Carolina Cardoso; Lívia Barbosa; Cecília Schubert Xavier Lagalhard Victer; Sueli Carneiro; Paulo Henrique Condeixa de França; Maria Chiara Chindamo; Cristiane Alves Villela-Nogueira;
10.1016/j.aohep.2024.101477
Examining genetic associations with hepatic steatosis in Mexican-origin adults Mario Jesus Trejo; Kristin E. Morrill; Yann C. Klimentidis; David O. Garcia;
Ann Hepatol. 2023;28: